These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5317911)

  • 61. Is bronchodilator response in 2-yr-old children associated with asthma risk factors?
    Lødrup Carlsen KC; Pettersen M; Carlsen KH
    Pediatr Allergy Immunol; 2004 Aug; 15(4):323-30. PubMed ID: 15305941
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Are we adequately managing children with wheeze using the standard case management guidelines?
    Lochindarat S; Qazi SA; Bunnag T; Nisar YB; Jatanachai P
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S60-8. PubMed ID: 19253498
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Study of the effect of decloxizine on central CO2 sensitive respiratory regulation of lung disease patients and arterial CO2 pressure in patients with bronchial obstruction and alveolar hypoventilation].
    Herberg D
    Acta Tuberc Pneumol Belg; 1968; 59(4):643-6. PubMed ID: 5739753
    [No Abstract]   [Full Text] [Related]  

  • 64. Influence of ambulatory inhaled treatment with different devices on the duration of acute asthma findings in children.
    Yilmaz O; Sogut A; Kose U; Sakinci O; Yuksel H
    J Asthma; 2009 Mar; 46(2):191-3. PubMed ID: 19253129
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Our experiences in the administration of Auxisolon (Auxison)].
    Marsenić B; Niksić M
    Plucne Bolesti Tuberk; 1972; 24(4):324-9. PubMed ID: 4601788
    [No Abstract]   [Full Text] [Related]  

  • 66. The authors respond to: Physician-ordered aerosol therapy versus respiratory therapist-driven aerosol protocol: effect on resource utilization.
    Kallam A; Modrykamien A
    Respir Care; 2013 Jul; 58(7):e83. PubMed ID: 23961560
    [No Abstract]   [Full Text] [Related]  

  • 67. Response to bronchodilator drugs in the first years of life.
    Milner AD
    Eur J Clin Pharmacol; 1980 Jul; 18(1):117-9. PubMed ID: 7398741
    [No Abstract]   [Full Text] [Related]  

  • 68. Selecting respiratory medications during the passover holiday.
    Chusid EL; Jerlinski AM
    Chest; 1982 Apr; 81(4):524-5. PubMed ID: 7067525
    [No Abstract]   [Full Text] [Related]  

  • 69. Bronchodilator delivery in the operating theatre.
    Wakeling H
    Anaesthesia; 1996 Aug; 51(8):794. PubMed ID: 8795333
    [No Abstract]   [Full Text] [Related]  

  • 70. New eye hazard.
    Neubert FR
    Br Med J; 1973 Aug; 3(5875):353. PubMed ID: 4723833
    [No Abstract]   [Full Text] [Related]  

  • 71. [Clinical experiences with a new bronchospasmolytic agent in infancy and childhood].
    Nachtigall C
    Med Monatsschr; 1968 Dec; 22(12):555-7. PubMed ID: 5709425
    [No Abstract]   [Full Text] [Related]  

  • 72. Airways flow resistance as a measure of the efficacy of inhalants in clinical drug trials.
    Cohen BM
    Helv Med Acta; 1969 Mar; 34(6):455-67. PubMed ID: 4888560
    [No Abstract]   [Full Text] [Related]  

  • 73. [Experience in using erespal in the treatment of acute respiratory diseases in children in outpatient practice].
    Chernenkov IuV; Gumeniuk OI; Popova IIu; Raskina EE; Doblo NN
    Vestn Otorinolaringol; 2010; (1):78-9. PubMed ID: 20524264
    [No Abstract]   [Full Text] [Related]  

  • 74. Rationale for spacer use in children.
    Dolovich M
    Pediatr Pulmonol Suppl; 1997; 16():184-5. PubMed ID: 9443266
    [No Abstract]   [Full Text] [Related]  

  • 75. [How can one test a bronchodilator agent in children?].
    Geubelle F; Senterre J; Abrassart C
    Acta Tuberc Pneumol Belg; 1964; 55(6):511-6. PubMed ID: 5317911
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.